Matched unrelated umbilical cord blood transplantation for a patient with chemotherapy resistant Wilms tumor

Kenneth G. Lucas, Terry Shapiro, Andrew Freiberg, Elizabeth Frauenhoffer

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

We report a patient with chemotherapy refractory Wilms tumor who underwent an unrelated donor cord blood transplant for chemotherapy refractory disease. The preparative regimen consisted of busulfan, melphalan, and anti-thymocyte globulin, and was well tolerated. This patient did not experience significant toxicity related to the chemotherapy regimen and did not develop any graft versus host disease from his HLA (A, B, DR) 6/6 matched cord blood transplant. Follow-up CT scans 2 years post-transplant have shown no evidence of disease progression, with only a few pulmonary nodules remaining, which are unchanged in size from his pre-transplant CT scan. It is possible that high-dose chemotherapy and stem cell transplantation can be curative in patients with tumors that are non-responsive to conventional chemotherapy. Pediatr Blood Cancer.

Original languageEnglish (US)
Pages (from-to)763-765
Number of pages3
JournalPediatric Blood and Cancer
Volume55
Issue number4
DOIs
StatePublished - Oct 1 2010

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Matched unrelated umbilical cord blood transplantation for a patient with chemotherapy resistant Wilms tumor'. Together they form a unique fingerprint.

  • Cite this